Cancer BX Carcinoma Virus 1

Rife Frequencies for

Frequency Player

Volume: 50%
Waveform:

About This Program

Cancer BX carcinoma virus is a microorganism historically associated with the early experimental work of Royal Raymond Rife, who theorized that certain pleomorphic organisms played a role in the development of carcinomas. In Rife frequency therapy, this program targets the BX carcinoma virus using a broad spectrum of electromagnetic frequencies applied in a non-invasive manner, with the intent of disrupting or devitalizing the associated pathogen while supporting the body's natural processes. Practitioners and researchers in the field of bioelectromagnetic therapy have long included BX-associated frequencies among the most historically significant in the Rife tradition. Users exploring this program may do so as a complementary approach alongside conventional care, and some report a sense of general support and well-being during use. Because cancer is a serious medical condition requiring professional oversight, it is strongly recommended that anyone considering frequency therapy for cancer-related concerns consult a qualified healthcare practitioner before beginning any program.

Frequencies (20)

  • 10025 Hz
  • 10026 Hz
  • 10027 Hz
  • 55 Hz
  • 127 Hz
  • 462 Hz
  • 590 Hz
  • 660 Hz
  • 690 Hz
  • 7275 Hz
  • 787 Hz
  • 852 Hz
  • 856 Hz
  • 880 Hz
  • 1582 Hz
  • 1755 Hz
  • 2008 Hz
  • 2120 Hz
  • 2127 Hz
  • 2008 Hz

Related Viruses Programs

View all Viruses programs →

Run all 20 Cancer BX Carcinoma Virus 1 frequencies at once

RifePlayer plays every Cancer BX Carcinoma Virus 1 frequency simultaneously — the fastest way to run a viruses program, finishing in minutes instead of hours. Experience the full power of frequency therapy with our advanced multi-frequency technology.

⚡ Instant access • 🎯 All frequencies • ⏱️ Faster treatments

Ready to start your healing journey?

Experience the power of rife frequency therapy with RifePlayer - the easiest way to use rife frequencies for your wellness.